An Updated Approach to the Diagnosis and Treatment of Enteric Fever: A Comprehensive Guide for Healthcare Professionals

Introduction

Enteric fever, predominantly caused by Salmonella Typhi and Paratyphi, remains a significant global health concern. Despite advances in diagnostics and therapeutics, the disease continues to pose challenges due to evolving bacterial resistance and variable clinical presentations. This article aims to provide an updated approach to the diagnosis and treatment of enteric fever.

Diagnosis

The gold standard for diagnosing enteric fever is blood culture, which has a sensitivity of 40-60% in the first week of illness. Bone marrow cultures increase the sensitivity to 80%, but are invasive and often not feasible. Serological tests like Widal test have poor specificity and sensitivity. Novel diagnostic methods such as PCR and antigen detection tests are promising, but require further validation before they can replace conventional methods.

Treatment

Antibiotic therapy is the mainstay of treatment. Historically, chloramphenicol, ampicillin, and cotrimoxazole were used, but resistance has led to the use of fluoroquinolones. However, fluoroquinolone-resistant strains have emerged, necessitating the use of third-generation cephalosporins or azithromycin. The choice of antibiotic should be guided by local susceptibility patterns. Adjunctive therapy includes hydration and electrolyte management.

Prevention and Control

Vaccination is an important preventive measure. Two vaccines are currently available: an oral live attenuated vaccine (Ty21a) and a parenteral polysaccharide vaccine (Vi). Both have comparable efficacy, but the Ty21a vaccine is preferred in children under 2 years. Improved sanitation, safe food and water practices are also essential in preventing enteric fever.

Conclusion

Enteric fever remains a significant health issue, particularly in developing countries. While advances have been made in diagnostics and treatment, challenges such as bacterial resistance and varying clinical presentations persist. Continued research, surveillance, and public health measures are crucial in the ongoing battle against this disease.